Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20890Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Papadopoulou, F. | en |
| dc.contributor.author | Efremidis, S. | en |
| dc.contributor.author | Karyda, S. | en |
| dc.contributor.author | Badouraki, M. | en |
| dc.contributor.author | Karatza, E. | en |
| dc.contributor.author | Panteliadis, C. | en |
| dc.contributor.author | Malaka, K. | en |
| dc.date.accessioned | 2015-11-24T19:11:01Z | - |
| dc.date.available | 2015-11-24T19:11:01Z | - |
| dc.identifier.issn | 0803-5253 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20890 | - |
| dc.rights | Default Licence | - |
| dc.subject | Adolescent | en |
| dc.subject | Ceftriaxone/administration & dosage/*adverse effects/therapeutic use | en |
| dc.subject | Cephalosporins/administration & dosage/*adverse effects/therapeutic use | en |
| dc.subject | Child | en |
| dc.subject | Child, Preschool | en |
| dc.subject | Cholelithiasis/*chemically induced/ultrasonography | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Infant | en |
| dc.subject | Infant, Newborn | en |
| dc.subject | Male | en |
| dc.subject | Prospective Studies | en |
| dc.subject | Time Factors | en |
| dc.subject | Urinary Bladder/ultrasonography | en |
| dc.title | Incidence of ceftriaxone-associated gallbladder pseudolithiasis | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/10626521 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1999 | - |
| heal.abstract | We prospectively evaluated the incidence of gallbladder pseudolithiasis in children treated with high doses of ceftriaxone for a variety of serious infections. We also monitored the time interval needed for this phenomenon to develop and resolve completely after initiation and cessation of treatment, respectively. Included in this study are 44 children treated with ceftriaxone 100 mg/kg/d divided into 2 equal intravenous doses and followed by serial abdominal sonography. Eleven children developed pseudolithiasis of gallbladder 2-9 d after initiation of ceftriaxone therapy. Six children (54.5%) developed this complication within the first 3 d. Lithiasis completely resolved 8-23 d after the end of treatment. In conclusion, pseudolithiasis of the gallbladder developed in 25% of sick children and completely resolved in all patients. Early development of this complication was not exceptional. It occurred in more than half of these children. | en |
| heal.journalName | Acta Paediatr | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Papadopoulou-1999-incidence of ceftriaxone.pdf | 111.57 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
